Atheroprotective mechanisms of HDL

Area of Science:

• Cardiovascular Science
• Biochemistry
• Molecular Biology

Background:

• Atherosclerosis is a complex, multistep process involving various molecular and cellular events.
• High-density lipoprotein (HDL) plays a crucial role in preventing atherosclerosis through multiple mechanisms.
• Understanding the specific contributions of HDL components is vital for developing targeted therapies.

Purpose of the Study:

• To synthesize current research on HDL's multifaceted roles in coronary heart disease (CHD) and atherosclerosis.
• To evaluate the impact of genetic modifications affecting HDL components on atherosclerosis development.
• To explore potential therapeutic strategies targeting HDL pathways.

Main Methods:

• Review of studies utilizing transgenic animal models to investigate HDL function.
• Analysis of data from genetic overexpression and deficiency models (e.g., apo AI, apo AIV, apo E, LCAT, CETP).
• Examination of the role of HDL receptors like SR-BI in cholesterol metabolism.

Main Results:

• Transgenic models confirm HDL's atheroprotective functions, including preventing LDL modification and reverse cholesterol transport.
• Apolipoprotein AIV (apo AIV) and apolipoprotein E (apo E) show significant roles in atherosclerosis prevention.
• Cholesteryl ester transfer protein (CETP) demonstrated atheroprotective effects contrary to previous assumptions, even with reduced HDL levels.
• LCAT overexpression showed mixed results across species, highlighting the need for caution in extrapolating findings from animal models to humans.

Conclusions:

• HDL components intervene at various stages of atherosclerosis, offering significant atheroprotective benefits.
• Genetic manipulation in animal models provides valuable insights into HDL's complex functions and therapeutic potential.
• Further research is needed to fully elucidate the roles of paraoxonase and apo J in human atherosclerosis and to validate findings from transgenic models for clinical application.